Future research should validate these mechanisms through longitudinal biomarker assessments, including cortisol and C-reactive protein, and investigate targeted interventions for depressive symptoms to reduce hypertension risk in populations exposed to ACEs. The gene discussed is CRP; the disease is Hypertension.